Delivery Order SPE2DB22D3401-SPE2DB25FT2WX
Award Date
3/26/25
Potential Completion Date
4/16/25
Potential Value
$6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,503.56 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ZYMFENTRA 120 MG/ML PEN (2PK)S. The order is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This contract allows Amerisourcebergen to supply a wide range of...
This is a $3,007.12 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide ZYMFENTRA 120 MG/ML PEN (2PK)S. The contract has an ultimate completion date of July 28, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to supply a wide range of pharmaceutical products and medical supplies in...
This is a $4,510.68 firm-fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Medical Supply Chain. The order is for ZYMFENTRA 120 MG/ML PEN (2PK)S, a pharmaceutical product. This award is not a set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies to support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZYMFENTRA 120 MG/ML PEN (2PK)S, a pharmaceutical product. The contract has a firm fixed price of $3,007.12 and a period of performance through June 4, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,212.90 firm fixed-price delivery order is for the supply of ZYMFENTRA 120 MG/ML PEN (2PK)S, with a performance period extending through June 4, 2025. The contract is not set aside and represents an open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,567,926,874 units of the medication ZYMFENTRA 120 MG/ML PEN KITS. The contract is a firm fixed-price delivery order with a ceiling value of $1,503.56 and a period of performance ending on May 6, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZYMFENTRA 120 MG/ML PEN (2PK)S, a medical product, with a ceiling value of $4,510.68 and a completion date of July 8, 2025. The contract is a Firm Fixed Price Delivery Order and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZYMFENTRA 120 MG/ML PEN KITS, with a ceiling value of $1,503.56 and a completion date of July 7, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type. It is not set aside for any specific business category. Amerisourcebergen Drug Corp is the prime contractor,...
This federal contract award is for the delivery of ZYMFENTRA 120 MG/ML PEN (2PK)S medical products to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $3,007.12. The contract is a Firm Fixed Price Delivery Order with a period of performance through July 28, 2025. There is no set-aside designation, indicating open competition. Amerisourcebergen...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,503.56 firm fixed-price contract is for the supply of ZYMFENTRA 120 MG/ML PEN KITS. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...